-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Raltegravir-d6
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1100750-98-82d.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 1100750-98-8 |
Product Information
| Synonyms | Raltegravir-d6;SCHEMBL13302571;DTXSID50716326;HY-10353S1;CS-0905602;1100750-98-8;N-{[4-Fluoro(~2~H_4_)phenyl](~2~H_2_)methyl}-5-hydroxy-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide; |
| IUPAC Name | N-[2-[4-[[dideuterio-(2,3,5,6-tetradeuterio-4-fluorophenyl)methyl]carbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide |
| Molecular Weight | 450.45 |
| Molecular Formula | C20H15D6FN6O5 |
| Canonical SMILES | O=C(C1=NN=C(O1)C)NC(C)(C2=NC(C(NC([2H])([2H])C3=C([2H])C([2H])=C(C([2H])=C3[2H])F)=O)=C(C(N2C)=O)O)C |
| InChI | InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)/i5D,6D,7D,8D,9D2 |
| InChIKey | CZFFBEXEKNGXKS-SOWAYKIMSA-N |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
